Laboratory for Molecular Infection Medicine Sweden

Laboratory for Molecular Infection Medicine Sweden
Name	Laboratory for Molecular Infection Medicine Sweden
Established	2009
Type	National research center
Focus	Molecular biology, Infection biology, Microbiology
Director	Bernt Eric Uhlin
Location	Umeå, Sweden
Affiliations	Umeå University, Swedish Research Council

Laboratory for Molecular Infection Medicine Sweden. It is a prominent national research center in Sweden dedicated to advancing the understanding of infectious diseases through molecular and cellular approaches. Established with significant strategic funding, the laboratory operates as a core facility within Umeå University, fostering interdisciplinary research at the intersection of microbiology, immunology, and host-pathogen interaction. Its mission is to provide cutting-edge technological platforms and scientific expertise to the national and international research community, aiming to translate fundamental discoveries into novel strategies for combating antimicrobial resistance and emerging pathogens.

History and establishment

The laboratory was formally established in 2009 following a major initiative by the Swedish Research Council and the Swedish Government to create a world-class infrastructure for infection biology research. The decision to base the center at Umeå University was influenced by the institution's longstanding strength in microbial genetics and molecular pathogenesis, notably under pioneers like Staffan Normark. Key driving figures in its formation included researchers such as Bernt Eric Uhlin and Åke Forsberg, who advocated for a centralized national resource. Its creation was part of a broader Swedish strategic investment in life sciences, aligning with national priorities set by VINNOVA and the Knut and Alice Wallenberg Foundation to enhance research competitiveness in biomedicine.

Research focus and scientific activities

The laboratory's research is centered on the molecular mechanisms of bacterial pathogenesis and the host's innate immune response. Core themes include the study of virulence factors in pathogens like Escherichia coli, Salmonella, and Neisseria gonorrhoeae, as well as investigations into biofilm formation and antibiotic tolerance. A significant portion of its work utilizes advanced genomics and proteomics to understand gene regulation during infection. Researchers also employ cell culture models and infection models to dissect cellular signaling pathways activated by microbial components, contributing directly to fields like sepsis research and vaccine development.

Organizational structure and funding

The laboratory operates as an integrated unit within the Faculty of Medicine at Umeå University, with its director reporting to the university leadership. Its core funding is provided through a long-term grant from the Swedish Research Council under the framework for research infrastructure. Additional financial support comes from competitive grants awarded by the European Commission, the Knut and Alice Wallenberg Foundation, and the Cancerfonden. Scientific oversight is provided by an international scientific advisory board comprising experts from institutions like the Max Planck Institute and Institut Pasteur. The center also hosts a graduate school for PhD students in infection biology.

Key facilities and technological platforms

The laboratory houses several state-of-the-art core facilities that are accessible to the broader scientific community. These include a comprehensive proteomics platform with mass spectrometry equipment for protein identification and quantification. Its imaging facilities feature advanced confocal microscopy, super-resolution microscopy, and electron microscopy for visualizing host-pathogen interactions. The genomics unit offers next-generation sequencing services and bioinformatics support for analyzing microbial genomes and transcriptomics data. Other critical platforms are dedicated to biosafety level laboratories, flow cytometry, and X-ray crystallography for structural studies of virulence proteins.

Notable achievements and impact

Research conducted at the laboratory has led to seminal discoveries in understanding how bacterial type III secretion systems inject effector proteins into host cells, a process critical for the virulence of pathogens like Yersinia pseudotuberculosis. Its scientists have made significant contributions to characterizing the role of small regulatory RNA in bacterial stress responses and antimicrobial resistance. The facility's work has been published in high-impact journals including Nature, Science, and Cell Host & Microbe. These findings have informed drug discovery efforts by pharmaceutical companies and influenced public health strategies managed by the World Health Organization and the European Centre for Disease Prevention and Control.

Collaborations and partnerships

The laboratory maintains extensive collaborative networks with leading academic and clinical institutions worldwide. Key national partners include the Karolinska Institutet, Lund University, and the Public Health Agency of Sweden. Internationally, it collaborates with the European Molecular Biology Laboratory, the Wellcome Sanger Institute, and several groups within the National Institutes of Health. It is a node in the Nordic EMBL Partnership for Molecular Medicine. Strategic industrial partnerships have been formed with bio-tech companies for technology development. The center also plays a pivotal role in European Union-funded projects under Horizon Europe frameworks aimed at tackling antimicrobial resistance.

Category:Research institutes in Sweden Category:Medical and health organizations based in Sweden Category:Umeå University